• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIP; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIP; PROTHROMBIN TIME TEST Back to Search Results
Model Number 99008G2
Device Problem Low Test Results (2458)
Patient Problems Coagulation Disorder (1779); Nausea (1970); Pain (1994); Thrombus (2101); Vomiting (2144); Hematuria (2558); No Code Available (3191)
Event Date 02/10/2014
Event Type  Injury  
Event Description
Caller alleged discrepant low inratio inr result in comparison to the laboratory inr result.On (b)(6) 2014, the patient's inratio inr result, in the primary care physician's office, was 2.0.Reportedly, the meter was not in the correct mode when finger stick was performed.The sample was not applied immediately after the finger stick and first drop of blood was not used.Additionally, improper capillary tube was used.The patient's target range is 2.0-3.0.Within one hour (12:14), the patient's laboratory inr result was 8.0.The (b)(6) , female patient presented with suprapubic and low back pain to the emergency room the same day.The pain was described as progressive in nature, stabbing in quality resulting in progression of nausea and vomiting.The patient is with a one day history of hematuria.Original computerized tomography (ct) scan, ordered by physician prior to onset of pain, showed no acute abnormality.The follow-up abdomen and pelvis ct scan in the emergency room revealed a very mild left hydronephrosis and some perirenal fluid consistent with possible fornical rupture.There was filling defects in the renal pelvis and ureter consistent with clots.The patient was admitted to the hospital and given pain medication, antiemetic, intravenous (iv) hydration and urology consultation ordered.The second laboratory inr (22:05) was 8.4.On (b)(6) 2014 (04:23), the laboratory inr was 6.9.Urology consultation was performed and correction of coagulopathy with 2 unites of fresh frozen plasma (ffp) given.Per urologist, the urethral clots would absorb spontaneously over time.Urologist offered to place ureteral stent; however, patient deferred.At 18:38 the inr was 3.3 and on (b)(6) 2014 (04:27) inr was 3.4.No discharge was provided.There was no additional information provided.
 
Manufacturer Narrative
Investigation pending.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIP
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
san diego CA
Manufacturer Contact
ya-ling king
9975 summers ridge rd
san diego, CA 92121
8588052084
MDR Report Key3687465
MDR Text Key4297568
Report Number2027969-2014-00195
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K110212
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 02/12/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number99008G2
Device Lot Number330238
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer02/19/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/12/2014
Initial Date FDA Received03/07/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
INRATIO 2 PT/INR PRO MONITOR SN 123738087; SYNTHROID 50MCG DAILY; LAST DOSE TAKEN; COUMADIN 4MG M/T/TH/F/SAT; AMOXICILLIN 50MG THREE TIMES DAILY; COUMADIN 6MG SUN/WED; VITAMIN D3 4000 UNITS DAILY; FLECAINIDE 10 MG TWICE DAILY; ATIVAN 0.5MG THREE TIMES DAILY AS NEEDED; ZOLOFT 100MG DAILY
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age76 YR
-
-